These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 17273162)

  • 1. Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis.
    Azam P; Sankaranarayanan A; Homerick D; Griffey S; Wulff H
    J Invest Dermatol; 2007 Jun; 127(6):1419-29. PubMed ID: 17273162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kv1.3 blockers ameliorate allergic contact dermatitis by preferentially suppressing effector memory T cells in a rat model.
    Ueyama A; Imura K; Kasai-Yamamoto E; Tai N; Nagira M; Shichijo M; Yasui K
    Clin Exp Dermatol; 2013 Dec; 38(8):897-903. PubMed ID: 24252082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases.
    Schmitz A; Sankaranarayanan A; Azam P; Schmidt-Lassen K; Homerick D; Hänsel W; Wulff H
    Mol Pharmacol; 2005 Nov; 68(5):1254-70. PubMed ID: 16099841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sceptridium ternatum attenuates allergic contact dermatitis-like skin lesions by inhibiting T helper 2-type immune responses and inflammatory responses in a mouse model.
    Lim D; Kim MK; Jang YP; Kim J
    J Dermatol Sci; 2015 Sep; 79(3):288-97. PubMed ID: 26150208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases.
    Beeton C; Pennington MW; Wulff H; Singh S; Nugent D; Crossley G; Khaytin I; Calabresi PA; Chen CY; Gutman GA; Chandy KG
    Mol Pharmacol; 2005 Apr; 67(4):1369-81. PubMed ID: 15665253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis--xenograft model.
    Kundu-Raychaudhuri S; Chen YJ; Wulff H; Raychaudhuri SP
    J Autoimmun; 2014 Dec; 55():63-72. PubMed ID: 25175978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of Kv1.3 potassium channels inhibits differentiation and granzyme B secretion of human CD8+ T effector memory lymphocytes.
    Hu L; Wang T; Gocke AR; Nath A; Zhang H; Margolick JB; Whartenby KA; Calabresi PA
    PLoS One; 2013; 8(1):e54267. PubMed ID: 23382885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block.
    Matheu MP; Beeton C; Garcia A; Chi V; Rangaraju S; Safrina O; Monaghan K; Uemura MI; Li D; Pal S; de la Maza LM; Monuki E; Flügel A; Pennington MW; Parker I; Chandy KG; Cahalan MD
    Immunity; 2008 Oct; 29(4):602-14. PubMed ID: 18835197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of regulatory T cells by leflunomide in a murine model of contact allergen sensitivity.
    Weigmann B; Jarman ER; Sudowe S; Bros M; Knop J; Reske-Kunz AB
    J Invest Dermatol; 2006 Jul; 126(7):1524-33. PubMed ID: 16543898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.
    Hu L; Pennington M; Jiang Q; Whartenby KA; Calabresi PA
    J Immunol; 2007 Oct; 179(7):4563-70. PubMed ID: 17878353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma.
    Koshy S; Huq R; Tanner MR; Atik MA; Porter PC; Khan FS; Pennington MW; Hanania NA; Corry DB; Beeton C
    J Biol Chem; 2014 May; 289(18):12623-32. PubMed ID: 24644290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting effector memory T-cells with Kv1.3 blockers.
    Wulff H; Pennington M
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):438-45. PubMed ID: 17659485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rutin suppresses atopic dermatitis and allergic contact dermatitis.
    Choi JK; Kim SH
    Exp Biol Med (Maywood); 2013 Apr; 238(4):410-7. PubMed ID: 23760007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice.
    Jung SH; Sun X; Ryu WS; Yang BS
    Br J Dermatol; 2013 Jan; 168(1):112-9. PubMed ID: 23020072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD.
    Saint-Mezard P; Krasteva M; Chavagnac C; Bosset S; Akiba H; Kehren J; Kanitakis J; Kaiserlian D; Nicolas JF; Berard F
    J Invest Dermatol; 2003 Apr; 120(4):641-7. PubMed ID: 12648229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models.
    Sheu MY; Fowler AJ; Kao J; Schmuth M; Schoonjans K; Auwerx J; Fluhr JW; Man MQ; Elias PM; Feingold KR
    J Invest Dermatol; 2002 Jan; 118(1):94-101. PubMed ID: 11851881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK inhibitor JTE-052 regulates contact hypersensitivity by downmodulating T cell activation and differentiation.
    Amano W; Nakajima S; Yamamoto Y; Tanimoto A; Matsushita M; Miyachi Y; Kabashima K
    J Dermatol Sci; 2016 Dec; 84(3):258-265. PubMed ID: 27665390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radix Saposhnikovia extract suppresses mouse allergic contact dermatitis by regulating dendritic-cell-activated Th1 cells.
    Yu X; Niu Y; Zheng J; Liu H; Jiang G; Chen J; Hong M
    Phytomedicine; 2015 Dec; 22(13):1150-8. PubMed ID: 26598913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
    Vennekamp J; Wulff H; Beeton C; Calabresi PA; Grissmer S; Hänsel W; Chandy KG
    Mol Pharmacol; 2004 Jun; 65(6):1364-74. PubMed ID: 15155830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally administered conjugated linoleic acid ameliorates allergic dermatitis induced by repeated applications of oxazolone in mice.
    Nakanishi T; Tokunaga Y; Yamasaki M; Erickson L; Kawahara S
    Anim Sci J; 2016 Dec; 87(12):1554-1561. PubMed ID: 26990926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.